On May 8, 2018 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) ("Rocket"), a leading U.S.-based multi-platform gene therapy company, reported that Gaurav Shah, M.D., Chief Executive Officer and President of Rocket, will present a company overview at the following investor conferences (Press release, Rocket Pharmaceuticals, MAY 8, 2018, View Source;p=irol-newsArticle&ID=2347578 [SID1234526275]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bank of America Merrill Lynch Health Care Conference 2018 on May 15, 2018, at 9:20 a.m. Pacific Time in Las Vegas, NV.
UBS Global Healthcare Conference on May 23, 2018, at 9:30 a.m. Eastern Time in New York City.
A live audio webcast of the UBS presentation will be available on the Investors section of the company’s website, www.rocketpharma.com. A replay of the presentation will be archived on the Rocket website following the conference.